On the use of intravenous immunoglobulins for the treatment of the antiphospholipid syndrome - A systematic review and meta-analysis

Autoimmun Rev. 2021 Jun;20(6):102828. doi: 10.1016/j.autrev.2021.102828. Epub 2021 Apr 15.

Authors

Tariq Anwar Lalmahomed¹, Isabel Johanna Walter², Anne Titia Lely², Katharina Wilhelmina Maria Bloemenkamp², Judith Kooiman², Maarten Limper³

Affiliations

¹ Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
² Department of Gynaecology and Obstetrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, the Netherlands.
³ Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: m.limper-2@umcutrecht.nl.

PMID: 33866065
DOI: 10.1016/j.autrev.2021.102828

No abstract available

Keywords: APS; Antiphospholipid syndrome; IVIG; Intravenous immunoglobulins; Obstetric.

Publication types

Letter
Meta-Analysis
Systematic Review

MeSH terms

Antibodies, Antiphospholipid
Antiphospholipid Syndrome* / drug therapy
Humans
Immunoglobulins, Intravenous* / therapeutic use
beta 2-Glycoprotein I

Substances

Antibodies, Antiphospholipid
Immunoglobulins, Intravenous
beta 2-Glycoprotein I